|
|
|
|
|
Characterization of Host-Cell Proteins Using Mass Spectrometry Enables Effective Purification Optimization
Lin Zang, Senior Scientist, Analytical Development, Biogen
4:00 pm, Wednesday, October 28, 2015
Lin Zang describes the mass spectrometry workflow for host cell protein identification that she will be presenting on at the BioProcess International Conference, and discusses the implications of HCPs on downstream process development.
Listen Now.
|
|
|
|
A Novel Approach to Monitor Clearance of Host Cell Proteins Associated with Monoclonal Antibodies
Min Zhu, Senior Scientist, Purification Process Sciences, MedImmune LLC
4:30 pm, Wednesday, October 28, 2015
The big challenge in downstream process development concerning host cell proteins is that the amount of HCPs in the purified product is often so low that it is hard to determine the identity of the HCP. She describes how the the approach she will be presenting at the conference overcomes this challenge.
Listen Now.
|
|
|
|
Implementing Multi-Attribute LC/MS Methods for More Informed Process Development
Matthew Traylor, Analytical Scientist, Process Development, Shire
9:20 am, Tuesday, October 27, 2015
Matthew Traylor discusses how he gets a deep characterization a specific protein out of a mixture, using LC/MS software packages that automate the process. He shares how this technology can be used at laboratory, pilot and production scale process development.
Listen Now.
|
|
|
|
Continued Process Verification (CPV) Informatics Systems and Validation
Carly Cox, Senior Process Engineer, Pfizer
9:20 am, Wednesday, October 28, 2015
Carly Cox describes what a CPV informatics system is and how it’s used in product manufacturing. She’ll be presenting at the BioProcess International Conference on how multiple source systems can pull data on product manufacturing processing and be collected into a CPV informatics system, and some of the important areas to consider for validation and configuration for regulatory reporting and process monitoring.
Listen Now.
|
|
|
|
Rapid Microbiological Methods for Real-Time Release of Autologous Cell Therapy Products
John Duguid, Principal Scientist, Vericel Corporation
2:00 pm, Thursday, October 29, 2015
Hear about how a risk based approach to autologous cell therapy products used at Vericel. In this podcast John Duguid describes how rapid microbiological methods are used in product release of autologous cell therapy products, and discusses the areas of contamination risk. Audio Player
Listen Now.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
This message comes to you from BioProcess International, One Research Drive, Suite 400A, Westborough, MA 01581.
If you would prefer not to receive further messages from this sender, please click on the following link to unsubscribe:
Click here to opt out
|
 
|
|
|
©2014 BioProcess International All Rights reserved
|
|
